Genome editing-based therapies typically aim to treat disease by correcting underlying genetic mutations in patient’s cells. However, most genetic disorders are caused by dozens or even thousands of ...

INSTALL results showed successful and safe non-viral insertion of large genetic payloads in the livers of mice when delivered by lipid nanoparticles (LNPs). In contrast, mice experienced fatal immune ...

Recently, GenScript made an announcement that demonstrated its commitment to supporting full non-viral cell therapy development into IND-enabling and clinical stages GenScript USA Inc., one of the ...

Assessment for anti-dsDNA antibodies provides some of the most significant challenges in autoantibody serology testing. Anti-dsDNA antibodies are an important biomarker for systemic lupus ...

Market Development ManagerDeNovix Inc. In this interview, Andrew Jones discusses the importance of quality control in next-generation sequencing and the effect that a poorly followed protocol can have ...

Please provide your email address to receive an email when new articles are posted on . Belimumab after rituximab reduces serum IgG anti-double-stranded DNA antibody levels and the risk for severe ...

Systemic lupus erythematosus (SLE) is characterized by autoantibody production, with anti-dsDNA antibodies (anti-dsDNA) being a key indicator for SLE diagnosis and disease monitoring. A new study ...

The data could help clinicians better identify patients who are good fits for belimumab after rituximab. A new study has identified biomarkers that may help predict which patients with systemic lupus ...